| Date |
Title |
Rating |
| 2011-03-31 |
Biota wins U.S. drug development contract for Laninamivir |
None |
| 2011-03-31 |
First Edition: March 31, 2011 |
None |
| 2011-03-31 |
Aetna commends FDA's decision on hydroxyprogesterone caproate |
None |
| 2011-03-31 |
SMFM praises FDA's announcement on Makena drug |
None |
| 2011-03-31 |
Health advocates file petition with U.N. over proposed trade agreement among several countries |
None |
| 2011-03-31 |
Researchers identify drug candidate that can treat prostate cancer |
None |
| 2011-03-31 |
Regulus obtains exclusive rights from NYU for miR-33a, 33b to treat metabolic diseases |
None |
| 2011-03-31 |
HHS unveils new website on vaccine and immunization for consumers |
None |
| 2011-03-30 |
AA Pharma launches Lithium Carbonate SR 300mg for Bipolar Disorder in Canada |
None |
| 2011-03-30 |
Traditional Chinese herbal medicine is an effective skin whitening cream |
None |
| 2011-03-30 |
McNeil takes voluntary action against certain OTC products in the U.S. |
None |
| 2011-03-30 |
DSP, Intercept enter license agreement for OCA |
None |
| 2011-03-30 |
Dr. Reddy’s acquires GSK's US penicillin facility and products |
None |
| 2011-03-30 |
FDA grants orphan drug status to America Stem Cell's ASC-101 |
None |
| 2011-03-30 |
Prostate cancer drug and a new drug to prevent preterm births cause cost concerns, controversy |
None |
| 2011-03-30 |
WHO Director-General responds to draft report on agency's handling of H1N1 pandemic |
None |
| 2011-03-30 |
Unilife initiates Unifill syringe production for pharmaceutical companies |
None |
| 2011-03-30 |
Merck submits Erbitux indication extension to EMA for NSCLC treatment |
None |
| 2011-03-30 |
Valeant receives European Commission marketing authorization for Trobalt |
None |
| 2011-03-30 |
ACCF, AHA guidelines recognize Effient as Class I treatment option for patients with ACS-PCI |
None |
| 2011-03-30 |
Orthopedic surgeons prefer Genzyme's 3-cycle hyaluronic-acid in the U.S., Europe |
None |
| 2011-03-30 |
Drugs' cost deters patients from taking heart medicine |
None |
| 2011-03-30 |
USPTO grants composition-of-matter patent to Zalicus 'Synavive' product |
None |
| 2011-03-30 |
Non-generic drugs increase Medicaid costs |
None |
| 2011-03-30 |
USPTO issues patent to Somaxon's Silenor food effect |
None |
| 2011-03-30 |
Researchers develop new drug for multiple cancer treatment |
None |
| 2011-03-30 |
EC grants marketing authorization for GSK, Valeant's Trobalt to treat epilepsy |
None |
| 2011-03-30 |
Oral antioxidant formulation before medical imaging may minimize cell damage |
None |
| 2011-03-29 |
Reports of H1N1 outbreaks in Venezuela, Mexico prompt quick preventive action by health authorities |
None |
| 2011-03-29 |
AstraZeneca, AmeriCares partner to deliver medicines for people with chronic conditions |
None |
| 2011-03-29 |
PerkinElmer expands epigenetic detection reagents portfolio for drug discovery |
None |
| 2011-03-29 |
Nycomed submits teduglutide MAA to EMA for SBS treatment |
None |
| 2011-03-29 |
Cardinal Health, APhA partner to prevent prescription medication abuse |
None |
| 2011-03-29 |
Atypical antipsychotics is a safe mental health medication for nursing home residents |
None |
| 2011-03-29 |
Scientists develop new model that can predict early adverse drug reactions |
None |
| 2011-03-29 |
USPTO issues Notice of Allowance to Modular's green surfactant patent application |
None |
| 2011-03-28 |
New pill may protect DNA from radiation damage |
None |
| 2011-03-28 |
Cancer drug Gleevec may hold promise against scleroderma: Study |
5 |
| 2011-03-28 |
Metagenics announces 2011 schedule for educational programs in lifestyle medicine |
None |
| 2011-03-28 |
Drugs can prevent risk of breast cancer in women, experts say |
None |
| 2011-03-28 |
RDY introduces Levocetirizine tablets in the U.S. market |
None |
| 2011-03-28 |
DAW prescriptions can increase annual health system costs to $7.7 billion |
None |
| 2011-03-28 |
MRF: FDA's decision on Yervoy offers new treatment options for patients with melanoma |
None |
| 2011-03-28 |
U.S. FDA approves Yervoy to treat patients with late-stage melanoma |
4 |
| 2011-03-28 |
University of Aberdeen, TPP enter agreement to develop novel future medicines |
None |
| 2011-03-28 |
Study establishes strong link between nicotine and diabetes complications |
None |
| 2011-03-28 |
CHPA issues statement in response to anti-consumer law on cold and allergy drugs |
None |
| 2011-03-28 |
FDA approves ipilimumab for metastatic melanoma treatment |
None |
| 2011-03-28 |
Anergis SA closes funding round for allergy vaccines |
None |
| 2011-03-28 |
U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit |
None |
| 2011-03-28 |
Panax ginseng, saffron and yohimbine can boost human sexual function |
None |
| 2011-03-28 |
Geriatrician provides latest Alzheimer drug research developments at International conference |
None |
| 2011-03-28 |
BMY receives FDA approval for YERVOY to treat metastatic melanoma |
4 |
| 2011-03-28 |
APP voluntarily recalls Irinotecan Hydrochloride Injection for precautionary measure |
None |
| 2011-03-28 |
NeoProteomics secures exclusive option agreement with Case Western Reserve University |
None |
| 2011-03-28 |
Scientists receive AACR Team Science Award for HPV research |
None |
| 2011-03-28 |
Zileuton can help reduce amyloid plaque formation and Alzheimer's development |
None |
| 2011-03-28 |
FDA approves ipilimumab to treat metastatic melanoma |
None |
| 2011-03-25 |
German company steps up production of Radiogardase following Japan nuclear crisis |
None |
| 2011-03-25 |
Study finds increased risk of VTE during first year of combination oral contraceptive usage |
None |
| 2011-03-25 |
'Dispense as written' prescriptions cost the health care system $7.7 billion annually |
None |
| 2011-03-25 |
US District Court rules against Watson in generic Fentora patent suit |
None |
| 2011-03-25 |
Merck to return rights for betrixaban to Portola |
None |
| 2011-03-25 |
Graceway receives FDA approval for Zyclara Cream to treat genital warts |
None |
| 2011-03-25 |
New study finds 74.8% increase in hospital emergency visits due to Ecstasy use |
None |
| 2011-03-25 |
Osteoporosis study: Protelos have significant bone-forming activity than bisphosphonates |
None |
| 2011-03-25 |
Antibiotic treatment does not benefit patients with discoloured phlegm |
None |
| 2011-03-25 |
Almac extends Pharma Services business unit to increase demand for storage capacity |
None |
| 2011-03-25 |
Parkinson's disease drugs may lead to impulse control disorders |
None |
| 2011-03-25 |
Althea extends labeling, packaging of biological product services through Sherpa |
None |
| 2011-03-25 |
New findings may make morphine a safer, more effective drug for chronic pain control |
None |
| 2011-03-25 |
Dabigatran etexilate is less costly, more effective for stroke treatment in patients with AF |
4 |
| 2011-03-25 |
Columbia University, Sanofi-aventis collaborate to develop innovative diabetes medicines |
None |
| 2011-03-25 |
USPTO issues Notice of Allowance to AlphaRx ARX8203 pain product candidate |
None |
| 2011-03-25 |
AACP selects Maryland professor for Pharmacy Educator Award |
None |
| 2011-03-25 |
Agilent opens new lab facility in Bangalore, India |
None |
| 2011-03-25 |
Researchers identify gene that can predict hypersensitivity to epilepsy drug |
None |
| 2011-03-25 |
APC-300 drug significantly inhibits pancreatic cancer cell growth: Adamis |
None |
| 2011-03-25 |
Sitagliptin drug can slow onset of diabetes |
5 |
| 2011-03-25 |
Merck & Co receives FDA approval for Zostavax vaccine to treat shingles |
None |
| 2011-03-24 |
Perceptive Informatics announces eClinical Product Suite survey results |
None |
| 2011-03-24 |
Pharmacists seek delay of rule limiting amount of dispensed drugs |
None |
| 2011-03-24 |
ASAM issues white paper to halt medical marijuana use |
2 |
| 2011-03-24 |
Colorcon announces specific details on its patent positions for enteric coatings |
None |
| 2011-03-24 |
Star Scientific's Ariva-BDL and Stonewall-BDL modified risk tobacco products not subject to FDC Act Chapter IX |
None |
| 2011-03-24 |
Prolia associated with greater adherence than alendronate in postmenopausal women with osteoporosis |
None |
| 2011-03-24 |
WHO report urges countries to step up fight against drug-resistant TB |
None |
| 2011-03-24 |
Resveratrol can provide resistance before and after hazardous radiation exposure |
1 |
| 2011-03-24 |
Xirrus deploys high performance Wi-Fi Arrays at EMA |
None |
| 2011-03-24 |
FTC: Granting pharmacists authority over PBMs may increase drug prices, reduce competition |
None |
| 2011-03-24 |
House bill proposes immunity for negligent drug manufacturers |
5 |
| 2011-03-24 |
Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment |
None |
| 2011-03-24 |
Oral contraceptive use before pregnancy does not pose respiratory problems in children |
None |
| 2011-03-24 |
New report shows 2% decrease in anxiolytic and hypnotic sales in Norway |
None |
| 2011-03-24 |
NephRx receives new U.S. patent for NX002 to treat IBD |
None |
| 2011-03-24 |
Actavis receives FDA marketing approval for generic Valtrex |
None |
| 2011-03-24 |
New research: Methadone can affect brain and impair intellectual functions |
None |
| 2011-03-24 |
USPTO grants patent to ULURU's Altrazeal product |
None |
| 2011-03-23 |
Ansell announces substantial price increase for NRL medical gloves |
None |
| 2011-03-23 |
Cilag, POZEN enter license agreement to develop and commercialize MT 400 |
None |
| 2011-03-23 |
NephRx receives new U.S. patent for NX002 to treat oral mucositis |
None |
| 2011-03-23 |
PRWP receives two new patents for Galectin-targeting compounds in the U.S., Australia |
None |
| 2011-03-23 |
SGEN, Abbott enter collaboration agreement for ADC products |
None |
| 2011-03-23 |
POZEN files motion for Treximet patent litigation against Par |
None |
| 2011-03-23 |
SMR, RTU enter license agreement for RESCULA eye drops |
None |
| 2011-03-22 |
Milk allergy successfully treated with Xolair |
4 |
| 2011-03-22 |
Multivitamin supplements can optimize body's metabolic performance |
None |
| 2011-03-22 |
USP teams up with FDA, CHPA to update quality standards for common medications |
None |
| 2011-03-22 |
Researchers launch free online Atlas of TB vaccination policies around the world |
None |
| 2011-03-22 |
AACP to honor UW professor with Volwiler Research Achievement Award |
None |
| 2011-03-22 |
Oral desensitization with omalizumab may treat milk allergy in children |
None |
| 2011-03-22 |
ACE, ARB combination therapy may increase risk of kidney failure, death |
None |
| 2011-03-22 |
FDA accepts Arisaph's ARI-3037MO IND for phase I human clinical trial |
None |
| 2011-03-22 |
BDSI's BEMA drug delivery technology receives Canada patent |
None |
| 2011-03-22 |
Researchers to develop house dust mite allergy vaccine that can cure asthma |
None |
| 2011-03-22 |
Watson introduces Famciclovir tablets to treat cold sores, genital herpes |
None |
| 2011-03-21 |
Hi-Tech Pharmacal acquires rights to Nystatin Oral suspension ANDA from Bausch + Lomb |
None |
| 2011-03-19 |
CHMP recommends approval of Centralized Marketing Authorization for Cinryze |
None |
| 2011-03-19 |
Government of Canada commits to contribute towards global effort to combat malaria |
None |
| 2011-03-19 |
BioMarin announces preliminary results from ADAPT in patients suffering from PKU |
None |
| 2011-03-19 |
Research roundup: Successful medical homes; shortage of HIV doctors; boosting use of $4 generic drugs |
None |
| 2011-03-19 |
Researchers identify protein that triggers immune response in TB-infected people |
None |
| 2011-03-18 |
EMA CHMP adopts negative opinion for Amgen's Vectibix in treatment of wild-type KRAS metastatic colorectal cancer |
None |
| 2011-03-18 |
EMA CHMP adopts positive opinion for Teva's NOMAC-E2 contraceptive pill |
None |
| 2011-03-18 |
Avid, Eli Lilly receive FDA complete response letter for Amyvid NDA |
None |
| 2011-03-18 |
MHA hosts two-day Long Term Care Business Summit at ARIA |
None |
| 2011-03-18 |
Medicare officials signal no payment changes on anemia drugs |
None |
| 2011-03-18 |
SCRIP to launch new pharma Lifecycle Management microsite |
None |
| 2011-03-18 |
Nature's Health announces record sales of 145% for Australian Dream pain relief cream |
None |
| 2011-03-18 |
Anacor Pharma, MMV enter agreement to develop AN3661 for malaria treatment |
None |
| 2011-03-18 |
New study: Men who consume hair loss drug may report sexual dysfunction |
1 |
| 2011-03-18 |
New drug can aid in smoking reduction therapy |
None |
| 2011-03-18 |
Brand name drug prices go up |
None |
| 2011-03-18 |
Positron to introduce its radiopharmaceutical system at American College of Cardiology |
None |
| 2011-03-17 |
GenSpera strengthens intellectual property for second prostate cancer drug |
None |
| 2011-03-17 |
Highmark forces patients with PIDD to switch over to specific IgG therapy |
None |
| 2011-03-17 |
pIMAGO nanopolymer can test cancer drug efficacy against biochemical processes |
None |
| 2011-03-17 |
Inovio signs agreement with OncoSec to sell non-DNA cancer vaccine technology |
None |
| 2011-03-17 |
Scientist suggests breaking tangled mucus barrier can help treat cancer |
None |
| 2011-03-17 |
ACEP, Poison Control Centers raise awareness about drug poisoning dangers |
None |
| 2011-03-17 |
New omalizumab medication may reduce seasonal asthma attacks in children |
None |
| 2011-03-17 |
Naltrexone may be effective in women with specific genetic variation |
None |
| 2011-03-17 |
Scientists to develop new universal vaccine against various flu viruses |
3 |
| 2011-03-17 |
Pharmaron signs agreement to provide Isis with nucleoside phosphoramidites up to 100 kg |
None |
| 2011-03-16 |
MorphoSys inks manufacturing agreement with Boehringer Ingelheim |
None |
| 2011-03-16 |
Nukepills.com donates 50,000 potassium iodide tablets to Tokushukai Hospital in Tokyo |
5 |
| 2011-03-16 |
Shanghai ChemPartner signs outsource research service agreement with Shenogen Pharma |
None |
| 2011-03-16 |
Researchers discover 3-D structure of key biological receptor |
None |
| 2011-03-16 |
Optimer receives U.S. patent for fidaxomicin to treat CDI |
None |
| 2011-03-16 |
Artesunate more effective against severe malaria |
2 |
| 2011-03-16 |
Study investigates physiological changes within brain due to Prozac treatment |
3 |
| 2011-03-16 |
Millennium, SGEN expand ADC collaboration |
None |
| 2011-03-16 |
Gadavist approved by FDA for use in central nervous system MRI scans |
None |
| 2011-03-16 |
NMS announces license agreement with Novartis |
None |
| 2011-03-15 |
Apeiron in antitumor substances deal with Cleveland Clinic |
None |
| 2011-03-15 |
Anavex to commence phase I clinical trial in Alzheimer’s disease |
None |
| 2011-03-15 |
Raymond Associates, BioNeutral enter global sales and distribution agreement for Ygiene antimicrobial technology |
None |
| 2011-03-15 |
Chelsea uses PHT's LogPad, SitePad Tablet for clinical study to treat Parkinson's patients with NOH |
None |
| 2011-03-15 |
InhibOx and COSMIC discoveries align to deliver full service drug discovery offering |
None |
| 2011-03-15 |
OncoSec signs agreement with Inovio to purchase non-DNA cancer vaccine technology |
None |
| 2011-03-15 |
Type 2 diabetes drug less likely to cause weight gain, raise cholesterol levels |
2 |
| 2011-03-15 |
Argentum responds to recent decision in patent lawsuit against Noble Biomaterials |
None |
| 2011-03-15 |
Study evaluates potential national savings from discount generic medication programs |
None |
| 2011-03-15 |
New study: Two peptide agent combination might block tumor growth |
None |
| 2011-03-15 |
USPTO grants second patent to Angiochem's EPiC drugs |
None |
| 2011-03-15 |
New findings may open doors for vaccine development against HIV, tuberculosis |
None |
| 2011-03-15 |
EC grants marketing authorization for Taiho's Teysuno to treat gastric cancer |
None |
| 2011-03-15 |
Study: Statin use may reduce risk of high-grade prostate cancer |
None |
| 2011-03-14 |
Bayer receives FDA approval for Gadavist Injection |
None |
| 2011-03-14 |
Indium oxine in development at Positron's Crown Point facility |
None |
| 2011-03-14 |
EvaluatePharma data shows poor R&D productivity measures both in quality, quantity |
None |
| 2011-03-14 |
AbCheck licenses CELEXION yeast display technology for an industry first |
None |
| 2011-03-14 |
SOM Biotech closes first financing round and files patent application |
None |
| 2011-03-14 |
SCLR announces FDA's issue of deficiency letter for pseudoephedrine ANDA |
None |
| 2011-03-14 |
CTI, Chroma enter agreement to co-develop and license tosedostat |
None |
| 2011-03-14 |
External panel issues draft report saying WHO response to H1N1 lacked cohesion, clarity |
None |
| 2011-03-14 |
Nanotechnology might provide greater efficacy of medicines for brain disease |
None |
| 2011-03-14 |
New insights into factors affecting adolescent marijuana use |
None |
| 2011-03-14 |
Tamoxifen against breast cancer can save lives and reduce medical costs |
None |
| 2011-03-14 |
New international research project to identify antibiotics against tuberculosis |
None |
| 2011-03-14 |
US District Court rules in favor of Watson in FENTORA patent litigation |
None |
| 2011-03-12 |
Provepharm receives favorable EMA Review of its methylthioninium chloride Proveblue |
None |
| 2011-03-12 |
New drug for Lupus approved |
1.5 |
| 2011-03-11 |
ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award |
None |
| 2011-03-11 |
Updated NCCN Guidelines for Breast Cancer outline expanded treatment options |
None |
| 2011-03-11 |
Scientific advances at Scripps Research lay foundation for new lupus drug Benlysta |
None |
| 2011-03-11 |
Simcere files IND with SFDA of China for APX003 to treat cancer |
None |
| 2011-03-11 |
PNP reaches several major objectives in cancer therapeutic product development |
None |
| 2011-03-11 |
FDA announces consent decree of permanent injunction against McNeil-PPC |
None |
| 2011-03-11 |
FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation |
None |
| 2011-03-11 |
OncoVista plans to advance reduced-toxicity targeted cancer treatments |
None |
| 2011-03-11 |
Canadian House of Commons passes bill that could ease access to generic drugs in developing countries |
None |
| 2011-03-11 |
Researchers concerned about use of mercury-based compound in inactivated flu vaccines |
None |
| 2011-03-11 |
Murad launches new powerhouse anti-aging treatment product |
5 |
| 2011-03-11 |
SAMHSA study finds 51.5% drug-related hospital visits by older patients |
None |
| 2011-03-11 |
Infant formulas with fluoridated water increase risk of discolored teeth: HHS |
5 |
| 2011-03-11 |
Eisai, Epizyme partner to develop and commercialize EZH2 epigenetic enzyme |
None |
| 2011-03-10 |
FDA approves Matrix NDA for Zidovudine Tablets |
None |
| 2011-03-10 |
Novartis new MS treatment receives Notice of Compliance in Canada |
None |
| 2011-03-10 |
FDA approves Covidien's LEU-based Mo-99 medical isotope |
None |
| 2011-03-10 |
Medtronic resolves FDA warning letters over Mounds View, Juncos facilities |
None |
| 2011-03-10 |
Despite aspirin therapy, specific inflammatory pathways may influence risk of colorectal cancer |
None |
| 2011-03-10 |
Pepscan signs Research and License Agreement with Crucell to devlop novel vaccines |
None |
| 2011-03-10 |
Scientists identify chemical compound that may lead to cancer-fighting drugs |
1 |
| 2011-03-10 |
AHF unveils new national advertising campaign about AIDS drugs |
None |
| 2011-03-10 |
CRT, ICR sign deal with ZoBio to discover and develop cancer drugs |
None |
| 2011-03-10 |
Opinions: Investing in science, technology; Indian public-private partnership for NTDs; U.S. global food security investments; Clinton's statements on PEPFAR; U.S. foreign aid; primary care |
None |
| 2011-03-10 |
FDA informs additional delay of ARYx's request for naronapride SPA |
None |
| 2011-03-10 |
FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus |
5 |
| 2011-03-10 |
Israel grants patent to Kamada's Transferrin for use in Pharmaceutical Compositions |
None |
| 2011-03-10 |
NCPA encourages patients on safe disposal of unwanted medications |
None |
| 2011-03-10 |
FDA accepts Merck's SAFLUTAN NDA for standard review |
None |
| 2011-03-10 |
Illicit drug users may face increased risk of microbial infections |
None |
| 2011-03-09 |
EDT receives European approval for XEPLION injection to treat schizophrenia |
1.7 |
| 2011-03-09 |
KineMed extends collaboration with BMY to identify and characterize Alzheimer's biomarkers |
None |
| 2011-03-09 |
U.S. FDA approves Hospira's docetaxel to treat variety of cancers |
None |
| 2011-03-09 |
New Australian drug approvals subject to budget cuts |
None |
| 2011-03-09 |
Human Genome Sciences receives FDA approval for Benlysta to treat lupus |
2 |
| 2011-03-09 |
Adamis submits APC-100 IND to FDA for treatment of prostate cancer |
None |
| 2011-03-09 |
MD Solarsciences launches new sunscreen lotion at 2011 AAD meeting |
5 |
| 2011-03-09 |
Oral magnesium oxide is a safe treatment for children with chronic constipation |
None |
| 2011-03-09 |
Variation in exposure to sunlight may affect sensitivity of individuals to drugs |
None |
| 2011-03-09 |
PILMA praises Senate for 2011 Patent Protection Act |
None |
| 2011-03-09 |
Yakult Honsha, AEZS sign agreement to develop, commercialize and license perifosine |
None |
| 2011-03-09 |
Also in global health news: Rights abuses in Myanmar; Indian malnutrition; Mali Global Fund grant; shift in USAID's programs in Afghanistan; Gates Foundation grant for vaccines |
None |
| 2011-03-09 |
Apotex passes Bill C-393 to fix Canada's Access to Medicines Regime |
None |
| 2011-03-09 |
USPTO grants new patent to Intellect's Alzheimer's vaccine |
None |
| 2011-03-09 |
New nitric oxide producing topical products support healing process |
None |
| 2011-03-09 |
Chemist discover new strategy to process certain drugs |
None |
| 2011-03-09 |
FDA accepts BMY and AstraZeneca's dapagliflozin NDA for review |
None |
| 2011-03-08 |
Patrys succeeds in obtaining commercial yields for its anti-cancer antibody therapeutic |
None |
| 2011-03-08 |
New insight into malaria |
None |
| 2011-03-08 |
Mississippi researchers work on drug discovey for poison ivy skin rash |
None |
| 2011-03-08 |
Anacor and iOWH establish research agreement to identify new drugs for shigellosis |
None |
| 2011-03-08 |
Discovery of potent class of anti-cancer compounds by Scripps Research and MIT scientists |
None |
| 2011-03-08 |
URMC research confirms possible use of mifepristone for painful fibroids |
None |
| 2011-03-08 |
Also in global health news: EU-India talks; China's health system funding; water in Ethiopia; nonprofit offering health services abroad to sell off assets; polio in India |
None |
| 2011-03-08 |
UCSF's new pharmacy to focus on direct patient care |
None |
| 2011-03-08 |
Ambry, RainDance enter new collaboration to develop and commercialize ADME screening |
None |
| 2011-03-07 |
New Lupus drug marching towards approval |
None |
| 2011-03-07 |
FDA says no cause for alarm on vaccines for meningitis and pneumonia |
None |
| 2011-03-07 |
5a-reductase inhibitors for male health problems can affect sexual health |
2 |
| 2011-03-07 |
Solasia, ZIOPHARM enter license and collaboration agreement for darinaparsin product |
None |
| 2011-03-07 |
Galderma, Astrazeneca collaborate to develop new compounds for dermatological disorders |
None |
| 2011-03-07 |
Launch Excellence Services provides solutions to new pharma product market entry |
None |
| 2011-03-07 |
FDA's action impacts Elite pharma drugs |
None |
| 2011-03-06 |
New research: Rectal specific microbicides can protect against HIV |
None |
| 2011-03-05 |
FDA approves change to prescribing information for Gilead Sciences' Letairis |
None |
| 2011-03-05 |
Deal Search Online: Pharma is the single most active sector in decade's health care M&A market |
None |
| 2011-03-05 |
New turf battle: Retail pharmacists vs. mail order companies |
None |
| 2011-03-05 |
FDA accepts Lundbeck's clobazam NDA for review |
2 |
| 2011-03-05 |
ADM, Burcon NutraScience enter license agreement to market CLARISOY soy protein |
None |
| 2011-03-05 |
Grifols receives FDA approval for Alphanate to treat vCJD |
None |
| 2011-03-05 |
Scientific symposium to examine new approaches to schizophrenia drug development |
None |
| 2011-03-05 |
Gates Foundation makes $10M PRI in Liquidia to support development of vaccines, therapeutics |
None |
| 2011-03-05 |
Football player announces release of new pre-workout intensity supplement |
None |
| 2011-03-05 |
Monthly liver enzyme tests not required for PAH patients taking Letairis tablets: FDA |
None |
| 2011-03-05 |
FDA approves Emoquette for prevention of pregnancy in women |
None |
| 2011-03-05 |
Topamax medication during pregnancy can lead to increased risk of oral birth defects in babies |
None |
| 2011-03-05 |
New research into drugs to prevent brain tumours in children wins vital funding |
None |
| 2011-03-04 |
Study: Resveratrol can reduce body fat |
None |
| 2011-03-04 |
Alcohol, marijuana and methamphetamines are common abuse substances |
None |
| 2011-03-04 |
Study: Vaccinated children and adolescents are less prone to infectious diseases |
None |
| 2011-03-04 |
New discovery holds promise for TB treatment |
None |
| 2011-03-04 |
European Commission approves BMY's ONGLYZA to treat type 2 diabetes |
None |
| 2011-03-04 |
Few primary care physicians pay adequate attention to patients taking prescription opioid drugs |
None |
| 2011-03-04 |
Protesters call on Indian government to reject free trade agreement with EU |
None |
| 2011-03-04 |
Shire receives European Commission approval for self-administration of FIRAZYR for HAE |
None |
| 2011-03-04 |
Exercise can reduce cannabis use in persons who don't want to stop |
None |
| 2011-03-03 |
Endo's FORTESTA Gel for treatment of 'Low T' in males is now available in pharmacies |
None |
| 2011-03-03 |
Eisai receives FDA approval for BANZEL Oral Suspension to treat seizures linked with LGS |
None |
| 2011-03-03 |
FDA approves Amneal's Indomethacin ER capsules |
None |
| 2011-03-03 |
EU's Avastin policy: A stark contrast to the FDA's recent decision |
None |
| 2011-03-03 |
EC grants marketing authorization for InterMune's Esbriet to treat IPF |
None |
| 2011-03-03 |
Roche, OraSure receive FDA 510(k) clearance for Oral Fluid Drug Testing System |
None |
| 2011-03-03 |
Real-life scientists search for new medicinal plants in remote areas |
None |
| 2011-03-03 |
Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality |
None |
| 2011-03-03 |
New Sanitized MedX 200s active ingredient series to reduce risk of HAI |
None |
| 2011-03-03 |
Celerion completes Clean Room, pharmacist certification to comply with USP 797 guidelines |
5 |
| 2011-03-03 |
CTI meets officials of FDA's OND to support pixantrone NDA |
None |
| 2011-03-03 |
FDA takes action against companies that manufacture unapproved prescription drugs |
None |
| 2011-03-03 |
Omeros identifies orphan GPCR compounds associated to pancreatic cancer, cognitive disorders |
None |
| 2011-03-03 |
New breakthrough in immunological research |
None |
| 2011-03-03 |
FADD protein discovery can lead to better cancer and autoimmune disease drugs |
None |
| 2011-03-03 |
Study: Men who consume non-steroidals more likely to have erectile dysfunction |
None |
| 2011-03-03 |
Portola, Accumetrics sign agreement to develop and supply VerifyNow System |
None |
| 2011-03-02 |
Ibuprofen may protect against development of Parkinson's disease |
None |
| 2011-03-02 |
IAVI, THSTI collaborate to establish HIV Vaccine Design Program in India |
None |
| 2011-03-02 |
Oxygen Biotherapeutics receives U.S. Army grant for studies of Oxycyte |
None |
| 2011-03-02 |
PreTreat Complete is now available for public to reduce migraine headaches |
None |
| 2011-03-02 |
Ipsen, Gtx terminate collaboration for development and commercialization of toremifene |
None |
| 2011-03-02 |
WARFARIN study to explore impact of genetic testing on individualized dosing |
3 |
| 2011-03-02 |
Study: Medication adherence alone may not benefit employees with chronic conditions |
None |
| 2011-03-02 |
Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications |
None |
| 2011-03-02 |
Trial date set for Teva's generic COPAXONE patent infringement litigation against Momenta |
None |
| 2011-03-02 |
Four pharmaceutical companies partner to create new single-source industry |
None |
| 2011-03-02 |
EMD Serono receives FDA CRL on Cladribine Tablets NDA for relapsing-remitting multiple sclerosis |
None |
| 2011-03-02 |
Baxter announces European rMRP approval of PREFLUCEL seasonal influenza vaccine |
None |
| 2011-03-02 |
U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI |
None |
| 2011-03-02 |
Study: 700,000 drug-related ED visits cost nearly $1.4 billion in 2007 |
None |
| 2011-03-02 |
Study: Pycnogenol- offers natural solution for patients with metabolic syndrome |
None |
| 2011-03-02 |
Research: Tanning bed exposure can lead to serious skin problems |
None |
| 2011-03-02 |
EPO to grant patent for Apricus MycoVa product to treat nail fungus |
3 |
| 2011-03-01 |
VaxInnate receives $196 million BARDA contract to develop novel flu vaccines |
None |
| 2011-03-01 |
European Commission approves BMY's BARACLUDE(r) to treat CHB in adult patients with liver disease |
None |
| 2011-03-01 |
FDA approves roflumilast to treat COPD |
1 |
| 2011-03-01 |
New drug approved for COPD by the FDA |
3 |
| 2011-03-01 |
New therapeutic strategy improves superior renal function after kidney transplantation |
None |
| 2011-03-01 |
FDA approves Forest Labs' Daliresp to treat COPD |
None |
| 2011-03-01 |
Anti-AIDS gel shows promise |
None |
| 2011-03-01 |
Medical experts propose six-point framework for safe production and use of Kava plant |
None |
| 2011-03-01 |
Decision Resources: 52% of surveyed cardiologists identify furosemide as efficacious acute heart failure therapy |
None |
| 2011-03-01 |
Excella achieves SafeBridge Potent Compound Safety Certification |
None |
| 2011-03-01 |
Meda launches Medivir's cold sore treatment Xerese in the U.S. |
None |
| 2011-03-01 |
Sweden's TLV confirms reimbursement for Qutenza patch for treatment of peripheral neuropathic pain |
None |
| 2011-03-01 |
Santaris licenses miR-33 from MGH to treat cardiovascular disorders |
None |
| 2011-03-01 |
Novavax announces agreement to license VLP vaccine technology to LGLS |
None |
| 2011-03-01 |
HP announces innovative drug research application for its inkjet technology |
None |
| 2011-03-01 |
AFFiRiS announces significant progress in collaboration with GSK for Alzheimer's vaccine development |
None |
| 2011-03-01 |
Nile plans to develop novel therapeutics for ADHF |
None |